Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden

被引:0
|
作者
Lue Ping Zhao
George K. Papadopoulos
Antonis K. Moustakas
George P. Bondinas
Annelie Carlsson
Helena Elding Larsson
Johnny Ludvigsson
Claude Marcus
Martina Persson
Ulf Samuelsson
Ruihan Wang
Chul-Woo Pyo
Daniel E. Geraghty
Åke Lernmark
机构
[1] Public Health Sciences Division,Laboratory of Biophysics, Biochemistry, Biomaterials and Bioprocessing, Department of Agriculture, Faculty of Agricultural Technology
[2] Fred Hutchinson Cancer Research Center,Department of Food Science and Technology, Faculty of Environmental Sciences
[3] University of Ioannina,Department of Pediatrics
[4] Ionian University,Department of Clinical Sciences
[5] Lund University,Department of Clinical and Experimental Medicine
[6] Lund University CRC,Department of Clinical Science and Education Karolinska Institutet and Institution of Medicine, Clinical Epidemiology
[7] Skåne University Hospital,Department of Medicine, Clinical Epidemiological Unit
[8] Crown Princess Victoria Children´S Hospital,Clinical Research Division
[9] Region Östergötland and Div of Pediatrics,undefined
[10] Linköping University,undefined
[11] Karolinska Institutet,undefined
[12] Karolinska Institutet,undefined
[13] Fred Hutchinson Cancer Research Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (αa1, α44, α157, α196) and (β9, β30, β57, β70, β135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, “DCAA-YSARD” (OR = 2.10, p = 1.96*10−20), “DQAA-YYARD” (OR = 3.34, 2.69*10−72) and “DQDA-YYARD” (OR = 3.71, 1.53*10−6) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (α44, β9, β30, β57 and β70), one was the N-terminal of the alpha chain (αa1), one in the CD4-binding region (β135), one in the putative cognate TCR-induced αβ homodimerization process (α157), and one in the intra-membrane domain of the alpha chain (α196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity.
引用
下载
收藏
相关论文
共 50 条
  • [21] Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden
    Carlsson, A.
    Kockum, I.
    Lindblad, B.
    Engleson, L.
    Nilsson, A.
    Forsander, G.
    Karlsson, A-K
    Kernell, A.
    Ludvigsson, J.
    Marcus, C.
    Zachrisson, I.
    Ivarsson, S-A
    Lernmak, A.
    INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (05) : 718 - 724
  • [22] Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden
    A Carlsson
    I Kockum
    B Lindblad
    L Engleson
    A Nilsson
    G Forsander
    A-K Karlsson
    A Kernell
    J Ludvigsson
    C Marcus
    I Zachrisson
    S-A Ivarsson
    Å Lernmark
    International Journal of Obesity, 2012, 36 : 718 - 724
  • [23] HLA-DQ genotypes in classic type 1 diabetes and in latent autoimmune diabetes of the adult
    Stenström, G
    Berger, MB
    Borg, H
    Fernlund, P
    Dorman, JS
    Sundkvist, G
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) : 787 - 796
  • [24] Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing
    Zhou, Zemin
    Reyes-Vargas, Eduardo
    Escobar, Hernando
    Chang, Kuan Y.
    Barker, Adam P.
    Rockwood, Alan L.
    Delgado, Julio C.
    He, Xiao
    Jensen, Peter E.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (02) : 314 - 326
  • [25] MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ
    Van Autreve, Jan E.
    Koeleman, Bobby P. C.
    Quartier, Erik
    Aminkeng, Folefac
    Weets, Ilse
    Gorus, Frans K.
    Van der Auwera, Bart J. R.
    HUMAN IMMUNOLOGY, 2006, 67 (1-2) : 94 - 101
  • [26] Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes
    van Lummel, Menno
    Duinkerken, Gaby
    van Veelen, Peter A.
    de Ru, Arnoud
    Cordfunke, Robert
    Zaldumbide, Arnaud
    Gomez-Tourino, Iria
    Arif, Sefina
    Peakman, Mark
    Drijfhout, Jan W.
    Roep, Bart O.
    DIABETES, 2014, 63 (01) : 237 - 247
  • [27] HLA-DQ Genotyping in Patients with Type 1 Diabetes Mellitus and Celiac Disease
    Agrawal, Neeraj
    Bhandari, Shweta
    Andleeb, Andleeb Zehra
    Singh, Usha
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 243 - 243
  • [28] The same HLA-DQ alleles determine either susceptibility or resistance to different coxsackievirus-mediated autoimmune diseases
    Luppi, P
    Alexander, A
    Bertera, S
    Noonan, K
    Trucco, M
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1999, 13 (01): : 14 - 26
  • [29] Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
    Zhao, Lue Ping
    Papadopoulos, George K.
    Kwok, William W.
    Moustakas, Antonis K.
    Bondinas, George P.
    Larsson, Helena Elding
    Ludvigsson, Johnny
    Marcus, Claude
    Samuelsson, Ulf
    Wang, Ruihan
    Pyo, Chul-Woo
    Nelson, Wyatt C.
    Geraghty, Daniel E.
    Lernmark, Ake
    DIABETES, 2020, 69 (07) : 1573 - 1587
  • [30] INSULIN-DEPENDENT DIABETES-MELLITUS SUSCEPTIBILITY OR PROTECTION MAY BE DETERMINED BY CERTAIN HLA-DQ MOLECULES
    THORSBY, E
    GJERTSEN, HA
    LUNDIN, KEA
    RONNINGEN, KS
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1991, 5 (03): : 361 - 373